ACT-660602

Cat. No. M21323

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

ACT-660602 is an oral chemokine receptor CXCR3 antagonist with an IC50 of 204 nM. It is being developed for use in autoimmune diseases.

Molecular Weight	534.48
Formula	C20H20F6N8OS
CAS Number	1646267-59-5
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related CXCR Products
Elubrixin Elubrixin (SB-656933) is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist.
VUF 11222 VUF 11222 is a CXCR3 non-peptide-like agonist.
(±)-AMG 487 (±)-AMG 487 is a racemate of AMG 487.
Elubrixin tosylate Elubrixin tosylate (SB-656933 tosylate) is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist.
Elubrixin hydrochloride Elubrixin (SB-656933) hydrochloride is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist.

Catalog